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ABBREVIATIONS 
AIC Akaike information criterion 
CI confidence interval 
ICD-O-3 International Classification of Diseases for 
Oncology, third edition 
NAEDI National Awareness and Early Diagnosis 
Initiative 
NCIN National Cancer Registration and Analysis 
Service 
NCRI National Cancer Research Institute 
OPCS Office of Population Censuses and Surveys 
OR odds ratio 
pph persons per hectare 
SAU small area unit 
TYA Teenagers and young adults 
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ABSTRACT 
Background: Studies have shown marked improvements in survival between 1981 and 2000 for Ewing 
sarcoma patients but not for osteosarcoma. This study aimed to explore socio-economic patterning in 
early mortality rates for both tumours.  
Procedure: The study analysed all 2432 osteosarcoma and 1619 Ewing sarcoma cases, aged 0-49 
years, diagnosed in Great Britain 1985-2008 and followed to 31/12/2009. Logistic regression models 
were used to calculate risk of dying within three months, six months, one year, three years and five 
years after diagnosis. Associations with Townsend deprivation score and its components were examined 
at small-area level. Urban/rural status was studied at larger regional level.  
Results: For osteosarcoma, after age adjustment, mortality at three months, six months and one year 
was associated with higher area unemployment, OR = 1·05 (95% CI 1·00, 1·10), OR = 1·04 (95% CI 
1·01, 1·08) and OR = 1·04 (95% CI 1·02, 1·06) respectively per 1% increase in unemployment. 
Mortality at six months was associated with greater household non-car ownership, OR = 1·02 (95% CI 
1·00, 1·03). For Ewing sarcoma, there were no significant associations between mortality and overall 
Townsend score, nor its components for any time period. For both tumours increasing mortality was 
associated with less urban and more remote rural areas.  
Conclusions: This study found that for osteosarcoma, early mortality was associated with residence 
at diagnosis in areas of higher unemployment, suggesting risk of early death may be socio-economically 
determined. For both tumours, distance from urban centres may lead to greater risk of early death.   
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1. Introduction 
Initiatives by the National Cancer Research Institute (NCRI), the National Cancer Intelligence Network 
(now the National Cancer Registration and Analysis service) and the National Awareness and Early 
Diagnosis Initiative (NAEDI) have highlighted the need for early diagnosis of cancer to improve survival 
[1]. Studies have suggested that childhood bone cancer has a longer time to diagnosis compared to 
some other childhood cancers and that a longer time to diagnosis is associated with older age for bone 
cancer in children, teenagers and young adults (TYA) [2, 3]. The TYA age (13-24 years) group 
represents a unique challenge to the UK National Health Service as they often straddle paediatric and 
older adult services, experience variation in treatment protocols compared to younger children and 
have to cope with a cancer diagnosis during a key developmental part of their lives [4].  
Previous studies have analysed incidence and survival from primary bone tumours using data from the 
northern part of England. In those analyses, over the twenty year period from 1981 to 2000 there were 
marked improvements in survival from Ewing sarcoma for children and for all patients aged less than 
40 years at time of diagnosis, whereas no improvements were seen in survival from osteosarcoma [5, 
6]. A previous national study of osteosarcoma and Ewing sarcoma survival data for those aged 0-39 
years did not fully investigate geographical patterns in survival rates [7]. A study from Germany showed 
that delays in diagnosis of bone tumours may be greater for patients resident in rural areas [8]. 
Differences in survival between countries have also been demonstrated. A comparative survival analysis 
of Ewing sarcoma patients between the UK and Germany found that survival rates were lower for UK 
patients [9]. Furthermore, a recent study from the USA suggested that socioeconomic factors influence 
overall survival for osteosarcoma [10]. Taken together these previous findings suggest that there are 
geographically determined factors which are related to mortality and survival amongst patients 
diagnosed with bone tumours.  
The aims of the present study were to determine if socio-economic patterning in early mortality rates 
for osteosarcoma and Ewing sarcoma were modulated by age, gender, area based measures of 
deprivation, and residence in urban or rural areas.  This should provide better understanding of the 
possible reasons for longer time to diagnosis in the UK compared to other similar countries. It should 
also allow the reasons for lack of improvement in early mortality, especially for osteosarcoma, to be 
elucidated.  
 
2. Methods 
2.1. Study Subjects 
The study population consisted of patients diagnosed with osteosarcoma or Ewing sarcoma in Great 
Britain between 1985 and 2008. Patients were followed to 31/12/2009 or date of death if earlier. The 
age range was limited to 0-49 years since there were very few Ewing sarcoma cases above this age 
and osteosarcoma over 50 years is most often DVVRFLDWHGZLWK3DJHW¶VGLVHDVHor is usually secondary 
to radiotherapy [11, 12].  
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The patient data were accessed from the ten former regional cancer registries that covered the whole 
of Great Britain. Patient data from the National Registry of Childhood Tumours [13] were also extracted 
and used to cross-check accuracy of data for those aged 0-14 years obtained from the regional 
registries. Analyses of these data showed similar results, and thus provided reassurance regarding data 
accuracy. The necessary regulatory and ethical approvals were obtained (UK National Research Ethics 
Service reference number 11/NE/0298). 
2.2. Diagnostic groups 
Cases were classified into diagnosis groups using the International Classification of Diseases for 
Oncology, third edition (ICD-O-3) [14]. The coding used information on both morphology and 
topography. Two specific diagnostic groups were specified a priori: (i) osteosarcoma (ICD-O-3 
topography codes for sites classified as bones and joint: C400-C403, C408-C414, C418-C419 and 
associated morphology codes 9180/3, 9181/3, 9182/3, 9183/3, 9184/3, 9185/3, 9186/3, 9187/3, 
9192/3, 9193/3, 9194/3, 9195/3) and (ii) Ewing sarcoma (ICD-O-3 topography codes for sites classified 
as bones and joint: C400-C403, C408-C414, C418-C419, C760-C768 and associated morphology codes 
9260/3, 9261/3). 
2.3. Outcome 
The possibility that time to diagnosis could increase in older age groups suggested that survival time 
might not be a robust outcome measure and mortality, as defined by the number of deaths in specified 
time intervals, would be more appropriate. Survival was recorded in the dataset as time in days from 
date of diagnosis to date of death or 31/12/2009 if vital status was recorded as alive at that date. 
Extremely early death is unusual in bone sarcoma and therefore patients with survival time equal to 0 
days were excluded from the analysis on the assumption that their true survival time was unknown. 
Mortality at each time point after diagnosis of three months, six months, one year, three years and five 
years was calculated where vital status was recorded as died and survival time was not greater than 
91, 182, 365, 1096, or 1826 days respectively. 
2.4. Boundary data 
Widespread boundary changes impede analyses over a prolonged time span, particularly at the small 
area level. Geo-referenced bone cancer registration data were linked to 2001 census boundaries [15]. 
The census boundaries consisted of wards in England and Wales (0±49 population ranges from 297 to 
29,300, median = 3,090) and postcode sectors in Scotland (0±49 population ranges from 23 to 15,916, 
median = 3,201). In England and Wales analyses were performed at the small area census ward level 
and in Scotland at the postcode sector level. The term small area unit (SAU) is used for convenience 
throughout this article. 
There are no formal urban/rural classifications of wards/postal sectors or other small areas that cover 
the whole of Great Britain and therefore two ways of examining the urban/rural nature of areas were 
chosen.  First, a scheme developed in 1991 by OPCS (Office of Population Censuses and Surveys) and 
updated by Champion and Norman was used. This grouped local authority areas into 13 area types 
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UDQJLQJIURPµ,QQHU/RQGRQ¶WRµ5HPRWHUUXUDO¶6HFRQGO\DPHDVXUHZDVFUHDWHGXVLQJµSHUVRQVSHU
KHFWDUH¶SSKLQWKHIROORZLQJZD\D6$8ZLWK!SSKZDVFODVVLILHGDVµ0RVWXUEDQ¶-SSKµ9HU\
XUEDQ¶-SSKµ8UEDQ¶-SSKµ5XUDO¶DQGSSKµ0RVWUXUDO¶ 
2.5. Demographic data 
Adjustment for deprivation was made using an area based, time-series of cross-sectional indicators. 
These were obtained from each of the censuses during the study period and geographically converted 
to be compatible with the 2001 SAUs [15]. The Townsend index is often used in similar geographical 
studies and comprises four components on unemployment, non-car ownership, non-home ownership 
and household overcrowding. To take account of any changes in deprivation for every SAU at the 
different time points, each Townsend component was expressed as a z-score relative to the GB average 
level over the study period. At each census time point, the z-scores were summed, equally weighted, 
to provide a set of deprivation scores in every SAU [16]. 
2.6. Statistical Analysis 
Logistic regression models analysed the odds of dying within three months, six months, one year, three 
years and five years after diagnosis. Three year and five year follow up data were only available for 
patients diagnosed 1985-2006 and 1985-2004 respectively and therefore the analyses of these time 
periods were carried out on a subset of the patients analysed at the shorter time periods. 
Associations with a time series of Townsend deprivation score and its components were examined at 
small-area level. The ecological (independent) variables were the census-derived small-area 
characteristics, which were DOORFDWHGWRWKHFHQVXVJHRJUDSK\XVLQJ1RUPDQ¶VPHWKRG [15].  
A series of univariable and multivariable models were fitted separately for osteosarcoma and Ewing 
sarcoma and included the following independent variables: sex, age group at diagnosis (0-14, 15-19, 
20-39 and 40-49 years), area based population density, Townsend score (as a composite). The four 
components of the Townsend score (percentage of overcrowded homes, percentage of households 
without a car, percentage of persons unemployed and percentage of homes that are not owner 
occupied) were included in separate models that did not include the composite score. Multivariable 
models comprised those variables which had shown a statistically significant relationship with mortality 
in a univariable model but only fitted if one of the variables was a deprivation variable i.e. Townsend 
composite score or a component. Model fit was assessed using the Akaike information criterion (AIC) 
with the final multivariable model selected as the one with the minimum AIC value. Interactions 
between age and the Townsend score and age and the individual Townsend components were 
considered for inclusion in the models. The likelihood ratio test was used to compare models with and 
without the interaction term. The effect of urban/rural area type on mortality was also examined using 
univariable logistic regression and then in multivariable models adjusting first for age and sex and then 
additionally but separately for Townsend score, area unemployment and non-car ownership in area of 
residence. Odds ratios (ORs) for the time periods from diagnosis are presented, together with 95% 
confidence intervals (CI). All analyses were carried out using STATA version 14.   
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3. Results 
There were 2432 cases of osteosarcoma (58·2% male) and 1619 cases of Ewing sarcoma (60.0% 
male)  included in the analysis after excluding those with survival equal to 0 days (1·3% of each 
cancer type). The demographic patient and area characteristics of the two groups are shown in Table 
1 (the Townsend deprivation score ranged from ±5·93 to 12·22 in 1971, -6·52 to 13·44 in 1981, -
6·04 to 12·34 in 1991 and -7·32 to 7·89 in 2001). The number of diagnoses and deaths in the two 
groups are shown in Table 2. Cumulative mortality increased from 1.7% at three months after 
diagnosis to 45.4% at five years for osteosarcoma patients and similarly from 2.0% at three months 
to 49.4% at five years for Ewing sarcoma patients (Table 1). The percentage of patients in each age 
group who had died at each time point are shown in Figures 1a and 1b. For osteosarcoma patients 
there was little variation over time between the age groups for those aged <=39 years but 
considerably more variation in mortality between all age groups for Ewing sarcoma patients and 
notably as time elapsed. 
3.1. Regression analysis: osteosarcoma 
Independent effects of demographic characteristics and area deprivation on mortality are shown in 
Supplemental Table S1. Mortality was significantly higher in the older age groups (20-49 years) 
compared to the youngest group (0-14 years) at three months and in those aged 40-49 years at all 
time points except five years. The impact on mortality of being diagnosed aged 40-49 years 
decreased over time, OR = 10·2 (95% CI 3·45, 29·6) at three months and OR = 1·42 (95% CI 0·99, 
2·05) at five years. There was no difference between males and females except at three and five 
years where mortality was lower for females, OR = 0·76 (95% CI 0·63, 0·91). 
For the area deprivation variables, small but statistically significant increases in mortality were seen 
with increasing unemployment at three months, six months and one year after diagnosis, increased 
households without a car, at six months and one year and an increase in the overall Townsend score, 
at one year.  As an example of the increase in mortality, the percentage of patients who died within 
three months of diagnosis increased by 5% for every one percent increase in unemployment (OR = 
1·05; 95% CI 1·01, 1·10). 
Multivariable logistic regression models were produced for the time points from diagnosis where at 
least one area deprivation variable had shown a significant association with mortality in the 
univariable analysis. The deprivation variable was adjusted for age group and sex and the models 
with the lowest AIC measure by time point are presented in Table 3 and again show a small but 
independent, significant effect of the deprivation variable after adjustment.  The likelihood ratio tests 
showed no effect of including interaction terms of age and the Townsend score (P = 0·79) or age and 
Townsend components (P = 0·39, 0·93, 0·80, 0·95 respectively for unemployment, home ownership, 
overcrowding and non-car ownership). 
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In the models examined at six months the AIC measure for % unemployment and age group was 
little different to that for % households without a car and age group (0·3107 versus 0·3106). In this 
model the effect on mortality of living in an area with increased unemployment was very similar to 
that of increasing non-car ownership (OR 1·04 [95% CI 1·01, 1·08]; P = 0·02). However when both 
unemployment and non-car ownership were included in a model and adjusted for age group, neither 
variable remained statistically significant. A scatter plot (Supplemental Figure S1) showed that while 
there was a positive relationship between increasing unemployment and increasing non-car 
ownership in many areas, at the same time there were also many areas where non-car ownership 
was high but in contrast unemployment was low. 
3.2. Regression analysis: Ewing sarcoma 
Results for the univariable regression analysis for Ewing sarcoma patients are shown in Supplemental 
Table S2. Mortality was associated with age, being significantly higher for those aged 20-49 years at 
diagnosis compared to those aged 0-14 years. This effect was seen at all time points after diagnosis. 
The effect of age on mortality decreased with elapsed time for those aged 20-39 years but there was 
no trend for the older age group (40-49 years). For patients aged 15-19 years at diagnosis, mortality 
was also significantly higher than the youngest age group at one year, three years and five years 
after diagnosis. Mortality was not shown to be significantly related to any deprivation variable and 
therefore no multivariable model was considered. 
3.3. Area type analysis 
The effects of area type on mortality using the first urban/rural measure are shown in Figures 2a 
(osteosarcoma patients) and 2b (Ewing sarcoma patients). Inner London was used as the baseline 
comparison group in both analyses. Differences in mortality in the osteosarcoma group seemed to 
appear away from the major urban areas and into the more remote areas. This was less apparent for 
the Ewing sarcoma group. 
Following these results, the effect of area type on mortality was examined further by adjusting for 
deprivation factors. Area type was firstly adjusted for age and sex to provide baseline measures and 
then additionally but separately for Townsend score, unemployment and non-car ownership.  
These analyses were carried out for the early mortality periods of three months, six months and one 
year post diagnosis. There were no interactions between area type and Townsend score in any time 
period or in either group. In both the osteosarcoma and Ewing sarcoma groups, there appeared to be 
no additional impact for deprivation at 3 months (data not shown). At six months for the 
osteosarcoma group, adjusting for Townsend score increased the effect of a small number of areas 
on mortality but the effect was increased to a greater extent and for an increased number of areas 
when adjusted for non-car ownership (Supplemental Table S3). In contrast, for Ewing sarcoma 
patients, these adjustments showed no effect on mortality at six months. For the osteosarcoma group 
at one year, the effect of area type on mortality increased most extensively when adjusted for either 
Townsend score or non-car ownership but in general the effect was strengthened more with non-car 
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ownership (Supplemental Table S4). Adjusting for deprivation factors in the Ewing sarcoma group on 
mortality at one year appeared to only have an impact on mortality for three area types. These were 
³oWKHUPHWURSROLWDQFLWLHV´ when adjusted for Townsend score, OR = 2.56 (95% CI 1·04, 6·29), 
³UHPRWHUXUEDQUXUDO´ZKHQDGMXVWHGIRU7RZQVHQG25= 3·40 (95% CI 1·16, 9·91) and no-car OR = 
2·95 (1·01, 8·DQG³VPDOOQRQ-PHWURSROLWDQFLWLHV´ZKHQDGMXVWHGIRU7RZQVHQG25= 3·64 (95% 
CI 1·23, 10·82), unemployment OR = 3·18 (95% CI 1·09, 9·25) and no-car OR = 3·23 (95% CI  
1·09, 9·52). Scatter plots showed differences in the relationship between area unemployment and 
non-car ownership by area type (Supplemental Figure S2). 
Using persons per hectare as a measure of urban/rural area type in the osteosarcoma group, showed 
no statistically significant differences in mortality for any period of follow-up between those areas 
ZLWKGHQVLW\FODVVLILHGDVµYHU\XUEDQ¶µXUEDQ¶µUXUDO¶RUµYHU\UXUDO¶FRPSDUHGWRµPRVWXUEDQ¶GDWD
not shown). Using the same measure for the Ewing sarcoma patients, again there were no 
VWDWLVWLFDOO\VLJQLILFDQWGLIIHUHQFHVFRPSDUHGWRµPRVWXUEDQ¶DUHDVEXWWKHUHGLGDSSHDUWREHDWUHQG
in the ORs showing increasing mortality in less urban and more rural areas for all periods except 
three months of follow-up (e.g. one year period, µPRVWXUEDQ¶25 = 1, µYHU\XUEDQ¶ OR = 0·85, µXUEDQ¶
OR = 1·µUXUDO¶25 = 1·µPRVWUXUDO¶25 = 1·27).  
 
4. Discussion 
We have identified socio-economic patterning in early mortality rates for patients aged 0-49 years 
diagnosed with osteosarcoma in GB. Specifically the study found that for osteosarcoma, mortality at 
three months, six months and one year after diagnosis was significantly associated with residence in 
areas of higher unemployment. There were no significant associations with deprivation at three or five 
years post-diagnosis. There were also no overall significant associations between early mortality for 
patients diagnosed with Ewing sarcoma and socio-economic deprivation. However, there was some 
evidence for an effect of deprivation for certain types of area. Increased risk of early death for both 
osteosarcoma and Ewing sarcoma was linked with residence in less urban and more remote rural areas. 
There may also be a link with non-car ownership, though it appears that owning a car is not equally 
essential for access to services in all areas. However, the analyses were ecological and so the findings 
may not necessarily apply to individuals. The magnitudes of the effects of deprivation and urban or 
rural area type were much more pronounced for osteosarcoma than for Ewing sarcoma.  
For both osteosarcoma and Ewing sarcoma mortality was significantly higher in older age groups (20-
49 years) compared to children (0-14 years). The study period, 1985-2008, was mainly prior to the 
development of dedicated TYA centres in GB. Although specialist bone cancer centres (covering a much 
wider age range) were already well established, the availability of specialist treatment centres for 
children could have contributed to lower early mortality for this age group. There were little or no 
differences between males and females.   
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There has been little or no improvement in survival from osteosarcoma during the last twenty years 
[17]. Without major improvements in treatment strategies, delivery of the best available treatment is 
of vital importance. Key factors that impede optimal treatment include delays in diagnosis, compliance 
and access to care. All of these factors might be socio-economically determined. Evidence suggests 
that of all cancer types, the time from first symptom to diagnosis are longest for bone tumour patients 
of all ages, but especially for TYA [2, 18]. Some recent initiatives by the NCIN and the National 
Awareness & Early Diagnosis Initiative (NAEDI) have emphasised the importance for early cancer 
diagnosis to make improvements in patient outcomes [1]. 
Little research has focussed on delays in diagnosis in patients with bone tumours. However, socio-
economic deprivation has been associated with worse survival for the more common cancers, including 
breast cancer and chronic myeloid leukaemia [19, 20]. The poorer outcomes associated with deprivation 
for breast cancer were attributed to both diagnostic delays as well as comorbidities.  Findings from our 
present study suggested that residence in areas of greater deprivation (specifically areas with higher 
rates of unemployment) was associated with worse early mortality for osteosarcoma. Also, residence 
in less urban and more remote rural areas was associated with increased risk of early death for both 
osteosarcoma and Ewing sarcoma. One possible interpretation of these findings is that diagnostic delays 
(patient and/or professional) may be greater in more deprived areas. Other issues may also contribute 
including distance from a specialist treatment centre (http://www.clicsargent.org.uk/content/long-way-
from-home-report). Another study from Germany found greater diagnostic delays in patients who were 
resident in rural areas [8]. 
A previous national UK study of osteosarcoma and Ewing sarcoma survival data did not fully investigate 
socio-economic patterning in survival rates [7]. Another comparative study found lower survival from 
Ewing sarcoma in UK patients compared with German patients [9]. This finding may be due to delays 
in referral or differences in treatment regimes. A few studies have examined the pre-diagnostic 
experiences amongst bone cancer patients.  A retrospective interview study from a specialist centre in 
Birmingham found significant delays, which ZHUHDWWULEXWHGWR µSURIHVVLRQDO¶GHOD\VDQGQRW µSDWLHQW¶
delays [21]. However, another study of thirty patients with osteosarcoma around the knee from 
Malaysia found that delays in diagnosis was associated with both patient and professional delays [22].   
A study of adherence to leukaemia maintenance therapy amongst children, adolescents and adults in 
south-eastern France found that low socio-economic status was associated with non-adherence to 
treatment [23]. A study from Brazil found that low educational level, but not low income, was associated 
with treatment compliance for chronic myeloid leukaemia [24]. A study from New York City found that 
housing needs amongst ethnic minorities was associated with lack of adherence to radiotherapy and 
chemotherapy [25]. However, access to health care in these three countries is markedly different from 
the UK, which has universal health insurance coverage. Nevertheless studies of common cancers 
suggest that access to care may be, at least partially, socio-economically determined, as postulated by 
WKHµLQYHUVHFDUHODZ¶)RUH[DPSOHDFFHVVPD\EHGHWHUPLQHGE\WUDYHOWLPHWRWKHWUHDWPHQWFHQWUH 
[26]. One study found that screening for oral cancer was inversely associated with lower uptake 
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amongst those most at risk [27]. Another study from the UK found that routes to diagnosis for sarcoma 
patients differ from other cancer [28]. However, access to care is unlikely to be socio-economically 
determined for children but for young people (ages 15-24 years) this is not the case as only around 
half are seen in regional specialist centres [29]. There is a need for studies of both compliance and 
access to care specifically for bone tumours in order to understand fully how these factors affect 
survival.  
In conclusion, this novel study has used a population-based dataset with very high levels of case 
ascertainment and novel geo-coding of cases to allocate area-based levels of socioeconomic status. 
However, staging and treatment data were not available. The findings suggest that risk of early death 
may be socio-economically determined in patients diagnosed with osteosarcoma. There was limited 
evidence for an effect of deprivation for Ewing sarcoma, but this was confined to limited areas. 
However, for both osteosarcoma and Ewing sarcoma increasing mortality was associated with less 
urban and more remote rural areas, suggesting that distance from urban centres may lead to greater 
risk of early mortality. Further research is needed to fully explore the factors that may have led to this 
disparity. These include delays in diagnosis (patient or professional), compliance with treatment and 
access to care. The magnitudes of the disparities suggest that there is much more scope for 
improvement for osteosarcoma than for Ewing sarcoma.  
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Figure Legends 
Figure 1a. Osteosarcoma cohort: Cumulative mortality at time after diagnosis by age group.              
(3 year and 5 year follow up restricted to those diagnosed 1985-2006 and 1985-2004 respectively) 
Figure 1b. Ewing Sarcoma cohort: Cumulative mortality at time after diagnosis by age group.             
(3 year and 5 year follow up restricted to those diagnosed 1985-2006 and 1985-2004 respectively) 
Figure 2a. Osteosarcoma: Effect of area on mortality (compared to Inner London) 
Figure 2b. Ewing Sarcoma: Effect of area on mortality (compared to Inner London) 
Supplemental Table Legends 
Supplemental Table 1. Osteosarcoma: Effect of age, sex and area deprivation markers on mortality 
(univariable analysis) in each time period 
Supplemental Table 2. Ewing Sarcoma: Effect of age, sex and area deprivation markers on mortality 
(univariable analysis) in each time period 
Supplemental Table 3. Osteosarcoma: Effect of area (compared to Inner London) on mortality at 6 
months post diagnosis, adjusted for age and sex and Townsend score, unemployment or non-car 
ownership (area sorted by OR when adjusted for age and sex). 
Supplemental Table 4. Ewing sarcoma: Effect of area (compared to Inner London) on mortality at 1 
year post diagnosis, adjusted for age and sex and Townsend score, unemployment or non-car 
ownership (area sorted by OR when adjusted for age and sex). 
Supplemental Figure Legends 
Supplemental Figure 1. Area unemployment and non-car ownership 
Supplemental Figure 2. Area unemployment and non-car ownership by area type 
 
 
15 
 
  
  
16 
 
  
